Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Mankind Pharma Financial Results

Mankind Pharma approved its audited FY26 results, reporting consolidated annual revenue of ₹14,277.64 Crore. The Board also cleared a ₹500 Crore investment in its Medicare subsidiary.

Source

NSE filing, NSE: MANKIND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Mankind Pharma Ltd: key numbers

Share price
₹2,490.00
Market cap
₹1,02,848 Cr
Revenue (annual)
₹14,278 Cr
Net profit (annual)
₹1,913 Cr
P/E (TTM)
45.9×Sector 46.1×
Promoter holding
72.62%-0.01% QoQ
FII holding
9.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mankind Pharma Ltd

All →
15:11 IST BSE
Financial Results

Mankind Pharma Q2 FY27 Results: Net Profit ₹716.1 Cr, Up 37.7% YoY

Mankind Pharma Ltd reported revenue from operations of ₹4,338 Cr (+17.3% YoY) and net profit of ₹716.1 Cr (+37.7% YoY) for Q2 FY27.

Key figure
Net profit ₹716.1 Cr · +37.7% YoY

Other financial results announcements

All →